Filing Details
- Accession Number:
- 0001708138-21-000026
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-23 16:02:45
- Reporting Period:
- 2021-06-21
- Accepted Time:
- 2021-06-23 16:02:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc. | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1226690 | George Yancopoulos | 777 Old Saw Mill River Road Tarrytown NY 10591 | President And Chief Scientific | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-01-12 | 82,108 | $0.00 | 82,108 | No | 5 | G | Indirect | By Trust for Chldn. |
| Common Stock | Disposition | 2021-06-21 | 738 | $532.89 | 81,370 | No | 4 | S | Indirect | By Trust for Chldn. |
| Common Stock | Disposition | 2021-06-21 | 7,494 | $533.66 | 73,876 | No | 4 | S | Indirect | By Trust for Chldn. |
| Common Stock | Disposition | 2021-06-21 | 8,236 | $534.48 | 65,640 | No | 4 | S | Indirect | By Trust for Chldn. |
| Common Stock | Disposition | 2021-06-21 | 4,154 | $535.63 | 61,486 | No | 4 | S | Indirect | By Trust for Chldn. |
| Common Stock | Disposition | 2021-06-21 | 3,768 | $536.37 | 57,718 | No | 4 | S | Indirect | By Trust for Chldn. |
| Common Stock | Disposition | 2021-06-21 | 6,636 | $537.61 | 51,082 | No | 4 | S | Indirect | By Trust for Chldn. |
| Common Stock | Disposition | 2021-06-21 | 4,868 | $538.54 | 46,214 | No | 4 | S | Indirect | By Trust for Chldn. |
| Common Stock | Disposition | 2021-06-21 | 3,306 | $539.66 | 42,908 | No | 4 | S | Indirect | By Trust for Chldn. |
| Common Stock | Disposition | 2021-06-21 | 8,099 | $540.61 | 34,809 | No | 4 | S | Indirect | By Trust for Chldn. |
| Common Stock | Disposition | 2021-06-21 | 19,911 | $541.44 | 14,898 | No | 4 | S | Indirect | By Trust for Chldn. |
| Common Stock | Disposition | 2021-06-21 | 10,514 | $542.43 | 4,384 | No | 4 | S | Indirect | By Trust for Chldn. |
| Common Stock | Disposition | 2021-06-21 | 2,276 | $543.13 | 2,108 | No | 4 | S | Indirect | By Trust for Chldn. |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | G | Indirect | By Trust for Chldn. |
| No | 4 | S | Indirect | By Trust for Chldn. |
| No | 4 | S | Indirect | By Trust for Chldn. |
| No | 4 | S | Indirect | By Trust for Chldn. |
| No | 4 | S | Indirect | By Trust for Chldn. |
| No | 4 | S | Indirect | By Trust for Chldn. |
| No | 4 | S | Indirect | By Trust for Chldn. |
| No | 4 | S | Indirect | By Trust for Chldn. |
| No | 4 | S | Indirect | By Trust for Chldn. |
| No | 4 | S | Indirect | By Trust for Chldn. |
| No | 4 | S | Indirect | By Trust for Chldn. |
| No | 4 | S | Indirect | By Trust for Chldn. |
| No | 4 | S | Indirect | By Trust for Chldn. |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Class A Stock | Acquisiton | 2021-04-15 | 14,000 | $0.00 | 14,000 | $0.00 |
| Common Stock | Class A Stock | Disposition | 2021-04-15 | 14,000 | $0.00 | 14,000 | $0.00 |
| Common Stock | Class A Stock | Disposition | 2021-04-15 | 5,383 | $0.00 | 5,383 | $0.00 |
| Common Stock | Class A Stock | Acquisiton | 2021-04-15 | 5,383 | $0.00 | 5,383 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 14,000 | No | 4 | G | Indirect | ||
| 0 | No | 4 | G | Indirect | ||
| 0 | No | 4 | G | Indirect | ||
| 5,383 | No | 4 | G | Indirect |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 987,483 | Direct | |
| Common Stock | 5,845 | Indirect | By 401(k) Plan |
| Common Stock | 211,585 | Indirect | by 2019 GRAT |
Footnotes
- As investment trustee of trusts for the benefit of the reporting person's children.
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- Represents volume-weighted average price of sales of 738 shares of Company stock on June 21, 2021 at prices ranging from $532.56 to $532.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.
- Represents volume-weighted average price of sales of 7,494 shares of Company stock on June 21, 2021 at prices ranging from $533.14 to $533.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.
- Represents volume-weighted average price of sales of 8,236 shares of Company stock on June 21, 2021 at prices ranging from $534.01 to $534.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.
- Represents volume-weighted average price of sales of 4,154 shares of Company stock on June 21, 2021 at prices ranging from $535.05 to $535.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.
- Represents volume-weighted average price of sales of 3,768 shares of Company stock on June 21, 2021 at prices ranging from $536.02 to $536.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.
- Represents volume-weighted average price of sales of 6,636 shares of Company stock on June 21, 2021 at prices ranging from $537.05 to $537.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.
- Represents volume-weighted average price of sales of 4,868 shares of Company stock on June 21, 2021 at prices ranging from $538.01 to $538.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.
- Represents volume-weighted average price of sales of 3,306 shares of Company stock on June 21, 2021 at prices ranging from $539.14 to $539.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.
- Represents volume-weighted average price of sales of 8,099 shares of Company stock on June 21, 2021 at prices ranging from $540.00 to $540.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.
- Represents volume-weighted average price of sales of 19,911 shares of Company stock on June 21, 2021 at prices ranging from $541.00 to $541.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.
- Represents volume-weighted average price of sales of 10,514 shares of Company stock on June 21, 2021 at prices ranging from $542.00 to $542.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.
- Represents volume-weighted average price of sales of 2,276 shares of Company stock on June 21, 2021 at prices ranging from $543.01 to $543.46. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.
- Class A Stock of Regeneron Pharmaceuticals, Inc. ("Regeneron") converts to Common Stock of Regeneron on a one-to-one basis upon certain events or upon election of the shareholder.
- These shares of Class A Stock are presently convertible and such conversion feature does not expire.
- These shares of Class A Stock are held in a trust for the benefit of the reporting person's child, of which the reporting person is trustee.
- These shares of Class A Stock were held in custody for the benefit of the reporting person's child.
Billionaire Hedge Funds
